We are live on ! Find out more
SC

Saturna Capital Portfolio holdings

AUM $7.13B
1-Year Est. Return 35.47%
This Fund
S&P 500
This Quarter Est. Return
-4.78%
1 Year Est. Return
+35.47%
3 Year Est. Return
+92.6%
5 Year Est. Return
+130.56%
10 Year Est. Return
+515.97%
AUM
$4.1B
AUM Growth
-$127M
Cap. Flow
+$145M
Cap. Flow %
3.54%
Top 10 Hldgs %
37.61%
Holding
170
New
9
Increased
52
Reduced
55
Closed
13

Top Buys

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$66.6M
2
CTVA icon
Corteva
CTVA
+$47M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$38.3M
4
TT icon
Trane Technologies
TT
+$30.1M
5
AMGN icon
Amgen
AMGN
+$25.7M

Top Sells

Rank Stock Value
1
INTU icon
Intuit
INTU
+$56.7M
2
NEM icon
Newmont
NEM
+$36.1M
3
GSK icon
GSK
GSK
+$12.7M
4
ABBV icon
AbbVie
ABBV
+$5.7M
5
PFE icon
Pfizer
PFE
+$2.43M

Sector Composition

Rank Sector Weight
1 Technology 37.46%
2 Healthcare 25.88%
3 Industrials 14.82%
4 Consumer Staples 8.05%
5 Consumer Discretionary 7.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UNP icon
26
Union Pacific
UNP
$178B
$60M 1.46%
308,002
-66
-0% -$14.6K
GPC icon
27
Genuine Parts
GPC
$17.6B
$59M 1.44%
395,010
-275
-0.1% -$41.5K
ITW icon
28
Illinois Tool Works
ITW
$81.9B
$57.3M 1.4%
317,346
+285
+0.1% +$56.2K
AZN icon
29
AstraZeneca
AZN
$263B
$57.2M 1.4%
521,517
+124,680
+31% +$15.8M
NSC icon
30
Norfolk Southern
NSC
$77.1B
$54.4M 1.33%
259,465
+2,115
+0.8% +$509K
PFE icon
31
Pfizer
PFE
$141B
$51.2M 1.25%
1,170,825
-50,054
-4% -$2.43M
IT icon
32
Gartner
IT
$9.87B
$50M 1.22%
180,641
BMY icon
33
Bristol-Myers Squibb
BMY
$128B
$48.7M 1.19%
684,397
+190
+0% +$13.8K
ORCL icon
34
Oracle
ORCL
$345B
$47.8M 1.17%
782,728
-1,240
-0.2% -$90.8K
CNI icon
35
Canadian National Railway
CNI
$78B
$44.1M 1.07%
408,000
HON icon
36
Honeywell
HON
$77.9B
$43.8M 1.07%
278,218
+43
+0% +$7.49K
PPG icon
37
PPG Industries
PPG
$26.4B
$42.8M 1.04%
386,580
+80
+0% +$9.89K
ABT icon
38
Abbott
ABT
$182B
$42.4M 1.03%
438,170
-300
-0.1% -$32K
AMD icon
39
Advanced Micro Devices
AMD
$807B
$42M 1.02%
662,985
-5,050
-0.8% -$430K
TXN icon
40
Texas Instruments
TXN
$255B
$41.4M 1.01%
267,252
+65
+0% +$10.9K
MKC icon
41
McCormick & Company Non-Voting
MKC
$13.6B
$40.8M 1%
573,156
-304
-0.1% -$25.5K
GWW icon
42
W.W. Grainger
GWW
$66B
$40M 0.98%
81,851
LECO icon
43
Lincoln Electric
LECO
$14.1B
$39.1M 0.95%
310,700
LIN icon
44
Linde
LIN
$234B
$36.8M 0.9%
136,528
QCOM icon
45
Qualcomm
QCOM
$179B
$36.3M 0.89%
321,634
-12,561
-4% -$1.73M
LULU icon
46
lululemon athletica
LULU
$13.4B
$30.7M 0.75%
109,845
+3,375
+3% +$1.05M
CL icon
47
Colgate-Palmolive
CL
$73.6B
$30.4M 0.74%
433,458
-508
-0.1% -$39.8K
HD icon
48
Home Depot
HD
$335B
$30.1M 0.74%
109,213
-74
-0.1% -$21.8K
FAST icon
49
Fastenal
FAST
$54.7B
$29.6M 0.72%
1,284,600
TT icon
50
Trane Technologies
TT
$107B
$29.2M 0.71%
+201,635
New +$30.1M

Similar funds

Saturna Capital's Q3 2022 Portfolio in Review

As of Q3 2022, Saturna Capital held 170 positions worth $4.1B, down 3% from $4.23B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Saturna Capital deployed $145M of net new capital in Q3 2022, opening 9 new positions and adding to 52 existing holdings. Its largest new stake was Elevance Health: 139,133 shares worth $63.2M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, down from 40% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Intuit, an estimated $56.7M trimmed.

  • Saturna Capital's largest Q3 2022 buy was Elevance Health: 139,133 shares worth $63.2M.
  • Saturna Capital added most to Corteva in Q3 2022, an estimated $47M increase.
  • Saturna Capital's biggest Q3 2022 reduction was Intuit, cutting an estimated $56.7M.
  • Saturna Capital fully exited Open Text in Q3 2022, selling an estimated $2.09M.
  • Saturna Capital's ten largest holdings make up 38% of its $4.1B portfolio in Q3 2022.
  • Saturna Capital opened 9 new positions and closed 13 in Q3 2022.
  • Saturna Capital's portfolio value fell 3% quarter-over-quarter to $4.1B.

Based on Saturna Capital's 13F filing for Q3 2022, filed 10 Nov 2022.